Skip to content
Abierto
Menu

Award notice

Office of Biomedical Advanced Research and Development Authority Broad Agency Announcement (BAA)

75A50124C00003

Office of Assistant Secretary for Preparedness and Response, Aspr Administration for Strategic Preparedness and Response. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Mapp Biopharmaceutical, Inc.

$38,199,745.00 on the award notice, March 19, 2024, contract 75A50124C00003

Description

As published on SAM.gov.

Mapp Biopharmaceuticals Inc.’s is to conduct safety and pharmacokinetic studies of MCMs in countries likely to experience naturally occurring outbreaks, while in parallel preparing each country to collect human clinical data in the event of outbreaks.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Mapp Biopharmaceutical, Inc.
UEI
M9V9QTHR1H28
CAGE
417U0
Vendor location
San Diego, CA
Contract
75A50124C00003, definitive contract
Obligated
$5,626,972.02, potential $38,242,688
Actions
13 between March 19, 2024 and August 12, 2026
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Development of Medical Countermeasures Through Planned Clinical Trials and Outbreak Preparedness
Match
award number 75A50124C00003 equals the contract number; same sub-agency 7505 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 21, 2024

    Award notice, originally solicitation

    Awarded to Mapp Biopharmaceutical, Inc. San Diego for $38,199,745. SAM.gov, notice 25b731ffdf67409c920179e0fed81dea

Points of contact

Also open from this buyer